EN
EN CH

API & intermediate

API & 中间体

立即提交
Intermediates
Generic drug intermediates Molecular building block
Upadacitinib
Switch other
Relugolix Ipatacopan Pemafibrate Elagolix Sodium Avatrombopag Maleate Eltrombopag Olamine Lumateperone Rimegepant
Nintedanib Elacestrant Elobixibat Upadacitinib Peramivir Lenvatinib Abrocitinib Crisaborole
Linzagolix Remibrutinib Zavegepant Milvexian Vericiguat Pacritinib Nemorexant Abemaciclib
Sparsentan Repotrectinib Elinzanetant Peficitinib
Intermediate name
CAS.No
structural formula
Intermediate name
CAS.No
structural formula
(3R,4S)-3-(2-溴乙酰基)-4-乙基-1-吡咯烷羧酸苄酯
1428243-26-8
(3R,4S)-3-(2-溴乙酰基)-4-乙基-1-吡咯烷羧酸苄酯
N-[5-[(4-甲基苯基)磺酰基]-5H-吡咯并[2,3-B]吡嗪-2-基]氨基甲酸乙酯
1869118-24-0
N-[5-[(4-甲基苯基)磺酰基]-5H-吡咯并[2,3-B]吡嗪-2-基]氨基甲酸乙酯
N- [5 - [(4-甲基苯基)磺酰基] -5H-吡咯并[2,3-B]吡嗪-2-基] - 氨基甲酸1,1-二甲基乙基酯
1201187-44-1
N- [5 - [(4-甲基苯基)磺酰基] -5H-吡咯并[2,3-B]吡嗪-2-基] - 氨基甲酸1,1-二甲基乙基酯
Intermediates
Generic drug intermediates Molecular building block
(3R,4S)-3-(2-溴乙酰基)-4-乙基-1-吡咯烷羧酸苄酯
N-[5-[(4-甲基苯基)磺酰基]-5H-吡咯并[2,3-B]吡嗪-2-基]氨基甲酸乙酯
N- [5 - [(4-甲基苯基)磺酰基] -5H-吡咯并[2,3-B]吡嗪-2-基] - 氨基甲酸1,1-二甲基乙基酯